Streetbeat News

Analyst Ratings

EL

JP Morgan analyst Andrea Teixeira maintains an Overweight rating on Estee Lauder Cos (NYSE:EL) but lowers the price target from $224 to $191.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:48 pm

GIS

JP Morgan analyst Ken Goldman maintains a Neutral rating on General Mills (NYSE:GIS) and lowers the price target from $75 to $71.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:47 pm

SHOP

Unusual options activity has been observed for Shopify (NYSE:SHOP), with a bearish stance taken by a large investor. The overall sentiment of these big-money traders is split between 45% bullish and 54% bearish. The price range targeted by these investors for Shopify over the last 3 months is from $45.0 to $100.0. RBC Capital, JMP Securities, Citigroup, and Goldman Sachs have maintained their ratings on Shopify, with price targets ranging from $65 to $80.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 2:46 pm

ASML

A significant bearish stance has been taken on ASML Holding (NASDAQ:ASML) as indicated by unusual options activity. Benzinga's options scanner spotted 17 uncommon options trades for ASML Holding, with the sentiment of these big-money traders being split between 29% bullish and 70% bearish. The whales have been targeting a price range from $230.0 to $800.0 for ASML Holding over the last 3 months. The price of ASML is currently down -0.55% at $651.71.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 2:45 pm

CAG

JP Morgan analyst Ken Goldman maintains a Neutral rating on Conagra Brands (NYSE:CAG) and lowers the price target from $38 to $37.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:45 pm

CPB

JP Morgan analyst Ken Goldman has maintained a Neutral rating on Campbell Soup (NYSE:CPB) and lowered the price target from $49 to $47.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:44 pm

ACOR

KERN

KNSA

PFE

SPOK

Benzinga Insights has identified five value stocks in the healthcare sector: Kiniksa Pharmaceuticals (KNSA), Pfizer (PFE), Akerna (KERN), Spok Holdings (SPOK), and Acorda Therapeutics (ACOR). These stocks are considered undervalued based on their low price-to-earnings (P/E) multiples. Recent earnings reports show increased earnings per share for KNSA, SPOK, and ACOR, while PFE's earnings per share decreased and KERN's remained negative.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 2:44 pm

AIRC

JP Morgan analyst Anthony Paolone has maintained a Neutral rating on Apartment Income REIT (NYSE:AIRC) and lowered the price target from $41 to $39.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:43 pm

TX

JP Morgan analyst Rodolfo Angele maintains an Overweight rating on Ternium (NYSE:TX) and raises the price target from $51.5 to $53.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:42 pm

NEXA

JP Morgan analyst Rodolfo Angele maintains a Neutral rating on Nexa Res (NYSE:NEXA) and raises the price target from $5.5 to $6.5.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:40 pm